Which funds own APGE
Apogee Therapeutics Inc in the Q2 2026 filings. At least 4 of the 91 current managers on file reported a position, worth $379m between them. It is among the largest positions of fewer than a fifth of the current managers on file. The quarter went one way: 4 managers opened or added against 1 cutting.
- Managers holding
- 4
- at least, of 91 current
- Combined value
- $379m
- as reported
- Opened
- 2
- new this quarter
- Added to
- 2
- already held
- Trimmed or sold out
- 1
- 1 sold out entirely
Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.
Managers reporting a position
Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.
| Manager | Value | Weight | Shares | Change on the quarter | Action |
|---|---|---|---|---|---|
| Balyasny Asset Management LLC Multi-strategy · $80.2bn book | $221m | 0.3% | 1,665,102 | +$184m+1,226,448 | Added |
| Soros Fund Management LLC Macro · $8.1bn book | $75m | 0.9% | 564,500 | opened564,500 | New |
| Woodline Partners LP Long/short equity · $32.4bn book | $62m | 0.2% | 464,622 | +$40m+203,502 | Added |
| Verition Fund Management LLC Multi-strategy · $19.7bn book | $21m | 0.1% | 159,256 | opened159,256 | New |
Sold out of this quarter
Valued at what the position was worth in the previous filing, because by this one it is gone.
- Capital World Investors · Long-only$29m held before
Ownership through time
At least 9 of the 95 managers whose filings are on file listed APGE in Q2 2026, against 2 in Q3 2023. 2 managers more than in Q1 2026: 3 started positions; 3 listed it again; 4 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.
Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.
- Q3 2023: 2
- Q4 2023: 3
- Q1 2024: 6
- Q2 2024: 2
- Q3 2024: 3
- Q4 2024: 4
- Q1 2025: 4
- Q2 2025: 3
- Q3 2025: 1
- Q4 2025: 5
- Q1 2026: 7
- Q2 2026: 9
- Q3 2023: $6.8m
- Q4 2023: $32m
- Q1 2024: $699m
- Q2 2024: $169m
- Q3 2024: $382m
- Q4 2024: $311m
- Q1 2025: $323m
- Q2 2025: $257m
- Q3 2025: $188m
- Q4 2025: $1.2bn
- Q1 2026: $1.5bn
- Q2 2026: $829m
Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.
Started in Q2 2026
Largest increases, by shares
- Balyasny Asset Management LLC438,654 to 1,665,102 shares+$163m
- Soros Fund Management LLCnew: 564,500 shares+$75m
- Woodline Partners LP261,120 to 464,622 shares+$27m
- Verition Fund Management LLCnew: 159,256 shares+$21m
- Moore Capital Management LPnew: 20,000 shares+$2.7m
Largest decreases, by shares
- Janus Henderson Group Ltd2,360,596 to 1,193,626 shares-$155m
Left it
No manager on file is shown leaving it.
| Manager | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Balyasny Asset Management LLC | Q1 2026 | $221m | $221m | |
| Millennium Management LLC | Q2 2026 | $198m | $198m | |
| Janus Henderson Group Ltd | Q4 2024 | $199m | $158m | |
| Soros Fund Management LLC | Q2 2026 | $75m | $75m | |
| Woodline Partners LP | Q3 2023 | $62m | $62m | |
| Man Group PLC | Q2 2026 | $53m | $53m | |
| Squarepoint Ops LLC | Q2 2026 | $39m | $39m | |
| Verition Fund Management LLC | Q2 2026 | $21m | $21m | |
| Moore Capital Management LP | Q2 2026 | $2.7m | $2.7m | |
| Fidelity (FMR LLC) | Q1 2024 | $780m | last listed Q1 2026 | |
| Wellington Management Group LLP | Q1 2024 | $368m | last listed Q1 2026 | |
| AllianceBernstein LP | Q4 2025 | $83m | last listed Q1 2026 | |
| Point72 Asset Management LP | Q4 2023 | $53m | last listed Q2 2025 | |
| Farallon Capital Management LLC | Q1 2024 | $20m | last listed Q1 2024 | |
| Capital World Investors | Q4 2024 | $9.3m | last listed Q1 2025 | |
| Holocene Advisors LP | Q4 2023 | $4.8m | last listed Q1 2026 | |
| PDT Partners LLC | Q1 2024 | $640k | last listed Q1 2024 | |
| Davidson Kempner Capital Management LP | Q3 2023 | $213k | last listed Q3 2023 |
What APGE is worth
Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.
Build the comp set around APGE →How much of the picture this is
A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.
What to do with a name the funds are buying
Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More
The holdings, every quarter, and the week between
One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.
One email a week, free, and you can leave at any point.